Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Eddy Lee Yip Hang

Issuer & Securities

Announcement Title: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
Date &Time of Broadcast: 26-Jul-2022 17:19:38
Status: New
Announcement Sub Title: Changes in Interest by Substantial Shareholder - Eddy Lee Yip Hang
Announcement Reference: SG220726OTHR75CR
Submitted By (Co./ Ind. Name): Gwendolin Lee Soo Fern
Designation: Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format): Please see attached.

This announcement has been prepared by iX Biopharma Ltd. (the Company) and its contents have been reviewed by the Company's Sponsor, UOB Kay Hian Private Limited (the Sponsor), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the SGX-ST) Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone: (65) 6590 6881.

if you are unable to view the above file, please click the link below.

Total size =151K